The Patent Finder

Inventisbio Co., Ltd.

30 patents currently held · Updated Nov 15, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Inventisbio Shanghai Ltd. (to 2021)

0
Ending by 2030
Aug 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 4, 2027
    The maintenance fee for Heterocyclic compounds, preparation methods therefor, and methods of uses thereof (US 11,691,981) comes due Jan 4, 2027. Unpaid by Jul 6, 2027, it lapses early.
  • 1 fee due Jul 9, 2027
    The maintenance fee for Heterocyclic compounds, preparation methods and uses thereof (US 11,865,115) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
  • 1 fee due Aug 20, 2027
    The maintenance fee for Novel Salts of Selective Estrogen Receptor Degraders (US 11,903,931) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.
  • 1 fee due Oct 30, 2027
    The maintenance fee for Inhibitor of indoleamine-2,3-dioxygenase (IDO) (US 11,969,425) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.
  • 1 fee due Nov 12, 2027
    The maintenance fee for Selective estrogen receptor degraders and uses thereof (US 10,647,724) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,809,580Carboxylic acid compound, method for preparation thereof, and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,856,239Carboxylic acid compound, method for preparation thereof, and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,179,784Pyrimidine or Pyridine Compounds, Preparation Method Therefor and Pharmaceutical Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 11,498,921Pyrimidine or pyridine compounds, preparation method therefor and pharmaceutical uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,647,724Selective estrogen receptor degraders and uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,014,936Selective estrogen receptor degraders and uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,187,736Selective estrogen receptor degraders and uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,980,807Inhibitor of indoleamine-2,3-dioxygenase (IDO)
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,969,425Inhibitor of indoleamine-2,3-dioxygenase (IDO)
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,685,720Salt Forms of URAT-1 Inhibitors
In force
 · Medium confidence
In forceMedium confidence
10 of 30 patents shown.
Pro members see all 30.
Pro members: see all 30 patents
Also on record, not counted in the 30: 1 patent in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

8 pending · 3 abandoned · 4 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited